216 related articles for article (PubMed ID: 24602471)
41. Role of therapeutic plasma exchanges in systemic vasculitis.
Régent A; Mouthon L; Guillevin L; Terrier B
Transfus Apher Sci; 2020 Dec; 59(6):102992. PubMed ID: 33172734
[TBL] [Abstract][Full Text] [Related]
42. [Plasma exchange in nephrology].
Jaques DA
Rev Med Suisse; 2023 Mar; 19(816):406-410. PubMed ID: 36876390
[TBL] [Abstract][Full Text] [Related]
43. Glomerular disease recurrence in the renal allograft: a hurdle but not a barrier for successful kidney transplantation.
Marinaki S; Lionaki S; Boletis JN
Transplant Proc; 2013; 45(1):3-9. PubMed ID: 23375268
[TBL] [Abstract][Full Text] [Related]
44. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.5. Chronic graft dysfunction. Late recurrence of primary glomerulonephritides.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():16-8. PubMed ID: 12091621
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results.
Mahr A; Chaigne-Delalande S; De Menthon M
Curr Opin Rheumatol; 2012 May; 24(3):261-6. PubMed ID: 22456283
[TBL] [Abstract][Full Text] [Related]
46. Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: a single center experience.
Mahesh S; Del Rio M; Feuerstein D; Greenstein S; Schechner R; Tellis V; Kaskel F
Pediatr Transplant; 2008 Sep; 12(6):682-8. PubMed ID: 18282212
[TBL] [Abstract][Full Text] [Related]
47. [Use of plasma exchange in treating kidney failure from paraproteinemic diseases].
Camerone G; Banfi L; Ferrari A; Garelli S; Valbonesi M
Riv Emoter Immunoematol; 1980; 27(3-4):168-74. PubMed ID: 7339846
[No Abstract] [Full Text] [Related]
48. Therapeutic plasma exchange: single-center experience in children with kidney disorders.
Joseph C; Siddiqui S; Shah S; Solomon CH; Srivaths PR
Pediatr Nephrol; 2021 Mar; 36(3):621-629. PubMed ID: 32949283
[TBL] [Abstract][Full Text] [Related]
49. Outcome of renal transplantation in patients with both ANCA and anti-GBM antibodies.
Raman G; Srivastava A; Geetha D
Transplantation; 2012 Sep; 94(5):e30-1. PubMed ID: 22955170
[No Abstract] [Full Text] [Related]
50. Plasma exchange in the treatment of early recurrent focal glomerulosclerosis after renal transplantation. Report and review.
Li PK; Lai FM; Leung CB; Lui SF; Wang A; Lai KN
Am J Nephrol; 1993; 13(4):289-92. PubMed ID: 8267030
[TBL] [Abstract][Full Text] [Related]
51. [Therapeutic plasma exchange: indications and results].
Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G
Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729
[No Abstract] [Full Text] [Related]
52. Plasmapheresis in immunologic renal disease.
Pusey CD; Levy JB
Blood Purif; 2012; 33(1-3):190-8. PubMed ID: 22269818
[TBL] [Abstract][Full Text] [Related]
53. Extracorporeal treatment of cast nephropathy.
Gakhar B; Kobrin S; Berns JS
Semin Dial; 2011; 24(1):9-11. PubMed ID: 21324000
[TBL] [Abstract][Full Text] [Related]
54. Focal and segmental glomerulosclerosis and plasma cell proliferative disorders.
Dingli D; Larson DR; Plevak MF; Grande JP; Kyle RA
Am J Kidney Dis; 2005 Aug; 46(2):278-82. PubMed ID: 16112046
[TBL] [Abstract][Full Text] [Related]
55. Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome.
Ulinski T
Curr Opin Organ Transplant; 2010 Oct; 15(5):628-32. PubMed ID: 20733489
[TBL] [Abstract][Full Text] [Related]
56. Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of Canadian experience.
Farah M; Levin A; Kiaii M; Vickars L; Werb R
Hemodial Int; 2013 Apr; 17(2):256-65. PubMed ID: 22928813
[TBL] [Abstract][Full Text] [Related]
57. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
Hind CR; Bowman C; Winearls CG; Lockwood CM
Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
[TBL] [Abstract][Full Text] [Related]
58. Spontaneous remission of proteinuria in recurrent focal glomerulosclerosis. Reappraisal of plasma exchange treatment.
Franco A; Peres R; Anaya F; Niembro E; Valderrabano
Clin Nephrol; 1987 Sep; 28(3):158. PubMed ID: 3311505
[No Abstract] [Full Text] [Related]
59. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
Cravedi P
G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
[TBL] [Abstract][Full Text] [Related]
60. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange.
Miller PJ; Farland AM; Knovich MA; Batt KM; Owen J
Am J Hematol; 2014 Jul; 89(7):695-7. PubMed ID: 24668845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
